Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic interventions for smoking cessation.

Robin L Corelli1, Karen Suchanek Hudmon

  • 1Department of Clinical Pharmacy, School of Pharmacy, University of California, 521 Parnassus Avenue, San Francisco, San Francisco, CA 94143, USA. corellir@pharmacy.ucsf.edu

Critical Care Nursing Clinics of North America
|March 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tobacco Use, Knowledge of Harms, and Treatment Support Among Patients With Non-Tobacco-Related Cancers: A Multi-Center Survey Study.

Cancer medicine·2026
Same author

A Co-Design Study Developing an Early Prototype Intervention to Support Oral Anticancer Medication Use in Breast Cancer.

Patient preference and adherence·2026
Same author

Collaborative development of a shared objective structured clinical examination to assess the pharmacist patient care process across two PharmD programs.

Currents in pharmacy teaching & learning·2026
Same author

Educational and Equity Implications of Biomarker Testing and Targeted Therapy Access in NSCLC: Insights from the NIH All of Us Research Program.

Journal of cancer education : the official journal of the American Association for Cancer Education·2025
Same author

Stakeholder feedback regarding a statewide protocol for pharmacists to prescribe tobacco cessation medications.

Exploratory research in clinical and social pharmacy·2025
Same author

Barriers and facilitators to implementing a brief tobacco cessation intervention during vaccine administration in community pharmacies: A mixed-methods study.

Journal of the American Pharmacists Association : JAPhA·2025

Healthcare providers should recommend pharmacotherapy for smoking cessation to most patients. This overview covers FDA-approved and other medications to aid tobacco cessation efforts.

Area of Science:

  • Pharmacology
  • Nursing
  • Public Health

Background:

  • The US Public Health Service recommends pharmacotherapy for smoking cessation.
  • Tobacco dependence is a significant public health issue requiring effective interventions.
  • Acute and critical care nurses play a vital role in supporting patients who want to quit smoking.

Purpose of the Study:

  • To provide an overview of pharmacologic agents for smoking cessation.
  • To guide acute and critical care nurses in selecting appropriate medications for tobacco-dependent patients.
  • To discuss various classes of smoking cessation pharmacotherapies.

Main Methods:

  • Review of first-line pharmacologic agents approved by the Food and Drug Administration (FDA) for smoking cessation, including nicotine replacement therapy and sustained-release bupropion.

Related Experiment Videos

  • Examination of second-line agents, such as nortriptyline and clonidine, which have demonstrated efficacy but lack FDA approval for smoking cessation.
  • Exploration of combination or high-dose therapy approaches, herbal remedies, and emerging pharmacotherapies currently under investigation.
  • Main Results:

    • First-line agents (nicotine replacement therapy, bupropion) are FDA-approved and effective for smoking cessation.
    • Second-line agents (nortriptyline, clonidine) show efficacy but are not FDA-indicated for this purpose.
    • Combination therapies, herbal options, and novel agents represent additional or future avenues for smoking cessation.

    Conclusions:

    • Pharmacotherapy is a cornerstone of smoking cessation interventions for most patients.
    • Nurses should be knowledgeable about various pharmacologic options to support tobacco cessation.
    • A range of therapeutic strategies, from FDA-approved medications to emerging treatments, can be employed to assist patients in quitting smoking.